Archives of Dermatological Research

, Volume 310, Issue 8, pp 639–650 | Cite as

Different Trypanosoma cruzi calreticulin domains mediate migration and proliferation of fibroblasts in vitro and skin wound healing in vivo

  • Jose Ignacio AriasEmail author
  • Natalia Parra
  • Carolina Beato
  • Cristian Gabriel Torres
  • Christopher Hamilton-West
  • Carlos Rosas
  • Arturo Ferreira
Original Paper


Calreticulin is an endoplasmic reticulum-resident, calcium-binding, stress-produced, chaperone protein that serves multiple functions and is widely distributed in eukaryotic cells. Exogenously applied recombinant calreticulin solution, markedly enhanced the rate and quality of skin wound healing. These modulatory effects are more efficient than commercially available topic platelet-derived growth factor ointments (Regranex®). Trypanosoma cruzi calreticulin is more effective in equimolar terms to human counterpart in accelerating skin wound healing. While the effect of externally added recombinant parasite calreticulin on wound healing has been reported, the domains responsible for these modulatory effects have not yet been established. Here, recombinant parasite calreticulin and some of its domains were tested to assess their influence in increasing proliferation and migration of fibroblasts in vitro and rat skin wound healing in vivo. Herein, we propose that Trypanosoma cruzi whole calreticulin or some of its domains are differentially involved in the modulation of wound-healing cell migration and proliferation, and cosmetic outcome. Therefore, precise combination of the parasite protein and its domains could allow us to tailor-specific desired effects during the skin wound-healing process.


Trypanosoma cruzi Calreticulin Domains Proliferation Migration Skin wound healing 



Research in the author’s laboratory was supported by the FONDECYT 11130257 Grant of CONICYT Chile. We thank Dr. David Carrino for his helpful suggestions in the preparation of this manuscript.

Compliance with ethical standards

Research involving human and animal rights

All animal procedures were approved by the local Animal Bioethics Committee in accordance with the International Guiding Principles for Biomedical Research Involving Animals, were developed by the Council for International Organizations of Medical Sciences (CIOMS), and were supervised by trained veterinary medical staff.


  1. 1.
    Abello-Caceres P, Pizarro-Bauerle J, Rosas C, Maldonado I, Aguilar-Guzman L, Gonzalez C, Ramirez G, Ferreira J, Ferreira A (2016) Does native Trypanosoma cruzi calreticulin mediate growth inhibition of a mammary tumor during infection? BMC Cancer 16:731CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Arias JI, Sepulveda C, Bravo P, Hamilton-West C, Maldonado I, Ferreira A (2015) Comparative effect of human and Trypanosoma cruzi calreticulin in wound healing. J Tissue Eng Regen Med 9:41–54CrossRefGoogle Scholar
  3. 3.
    Baldo BA (2014) Side effects of cytokines approved for therapy. Drug Saf 37:921–943CrossRefPubMedGoogle Scholar
  4. 4.
    Bayat A, McGrouther DA, Ferguson MWJ (2003) Skin scarring. Brit Med J 326:88–92CrossRefPubMedGoogle Scholar
  5. 5.
    Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117:1219–1222CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Briquez PS, Hubbell JA, Martino MM (2015) Extracellular matrix-inspired growth factor delivery systems for skin wound healing. Adv Wound Care 4:479–489CrossRefGoogle Scholar
  7. 7.
    Burns K, Duggan B, Atkinson EA, Famulski KS, Nemer M, Bleackley RC, Michalak M (1994) Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 367:476–480CrossRefPubMedGoogle Scholar
  8. 8.
    Cheng B, Liu H-W, Fu X-B, Sun T-Z, Sheng Z-Y (2007) Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats. J Dermatol Sci 45:193–201CrossRefPubMedGoogle Scholar
  9. 9.
    DiPietro LA (2016) Angiogenesis and wound repair: when enough is enough. J Leukoc Biol 100:979–984CrossRefPubMedGoogle Scholar
  10. 10.
    Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366:1736–1743CrossRefPubMedGoogle Scholar
  11. 11.
    Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabe-Heider F, Biernaskie J, Junek A, Kobayashi NR, Toma JG, Kaplan DR, Labosky PA, Rafuse V, Hui CC, Miller FD (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6:1082–1093CrossRefPubMedGoogle Scholar
  12. 12.
    Ferreira V, Molina MaC, Valck C, Rojas Á, Aguilar L, Ramírez G, Schwaeble W, Ferreira A (2004) Role of calreticulin from parasites in its interaction with vertebrate hosts. Mol Immunol 40:1279–1291CrossRefPubMedGoogle Scholar
  13. 13.
    Ferreira V, Valck C, Sanchez G, Gingras A, Tzima S, Molina MC, Sim R, Schwaeble W, Ferreira A (2004) The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J Immunol 172:3042–3050CrossRefPubMedGoogle Scholar
  14. 14.
    Frykberg RG, Banks J (2015) Challenges in the treatment of chronic wounds. Adv Wound Care 4:560–582CrossRefGoogle Scholar
  15. 15.
    Galiano RD, Michaels VJ, Dobryansky M, Levine JP, Gurtner GC (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12:485–492CrossRefPubMedGoogle Scholar
  16. 16.
    Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Löndahl M, Price PE, Jeffcoate WJ, On behalf of the International Working Group on the Diabetic Foot (IWGDF) (2016) Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev 32:154–168CrossRefPubMedGoogle Scholar
  17. 17.
    Garrido O, Letelier R, Rosas C, Fuenzalida M, Ferreira A, Lemus D (2010) Betamethasone inhibits tumor development, microvessel density and prolongs survival in mice with a multiresistant adenocarcinoma TA3. Biol Res 43:317–322CrossRefPubMedGoogle Scholar
  18. 18.
    Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE (2010) Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB 24:665–683CrossRefGoogle Scholar
  19. 19.
    Gold LI, Rahman M, Blechman KM, Greives MR, Churgin S, Michaels J, Callaghan MJ, Cardwell NL, Pollins AC, Michalak M, Siebert JW, Levine JP, Gurtner GC, Nanney LB, Galiano RD, Cadacio CL (2006) Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects. J Investig Dermatol Symp Proc 11:57–65CrossRefPubMedGoogle Scholar
  20. 20.
    Gonzalez A, Valck C, Sanchez G, Hartel S, Mansilla J, Ramirez G, Fernandez MS, Arias JL, Galanti N, Ferreira A (2015) Trypanosoma cruzi calreticulin topographical variations in parasites infecting murine macrophages. Am J Trop Med Hyg 92:887–897CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Gowda S, Weinstein DA, Blalock TD, Gandhi K, Mast BA, Chin G, Schultz GS (2015) Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response. Int Wound J 12:564–571CrossRefPubMedGoogle Scholar
  22. 22.
    Greenhalgh DG, Sprugel KH, Murray MJ, Ross R (1990) PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136:1235–1246PubMedPubMedCentralGoogle Scholar
  23. 23.
    Greives MR, Samra F, Pavlides SC, Blechman KM, Naylor S-M, Woodrell CD, Cadacio C, Levine JP, Bancroft TA, Michalak M, Warren SM, Gold LI (2012) Exogenous calreticulin improves diabetic wound healing. Wound Repair Regen 20:715–730CrossRefPubMedGoogle Scholar
  24. 24.
    Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127:526–537CrossRefPubMedGoogle Scholar
  25. 25.
    Hosgood G (2006) Stages of wound healing and their clinical relevance. Vet Clin North Am Small Anim Pract 36:667–685CrossRefPubMedGoogle Scholar
  26. 26.
    Iruela-Arispe ML, Dvorak HF (1997) Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 78:672–677CrossRefPubMedGoogle Scholar
  27. 27.
    Johnson V, Webb T, Norman A, Coy J, Kurihara J, Regan D, Dow S (2017) Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections. Sci Rep 7:9575CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Jozic I, Vukelic S, Stojadinovic O, Liang L, Ramirez HA, Pastar I, Tomic Canic M (2017) Stress signals, mediated by membranous glucocorticoid receptor, activate PLC/PKC/GSK-3beta/beta-catenin pathway to inhibit wound closure. J Invest Dermatol 137:1144–1154CrossRefPubMedGoogle Scholar
  29. 29.
    Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13:1211–1233CrossRefPubMedGoogle Scholar
  30. 30.
    Labriola C, Cazzulo JJ, Parodi AJ (1999) Trypanosoma cruzi calreticulin is a lectin that binds monoglucosylated oligosaccharides but not protein moieties of glycoproteins. Mol Biol Cell 10:1381–1394CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Langer A, Rogowski W (2009) Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res 9:115CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Le Provost GS, Pullar CE (2015) [beta]2-adrenoceptor activation modulates skin wound healing processes to reduce scarring. J Invest Dermatol 135:279–288CrossRefPubMedGoogle Scholar
  33. 33.
    Lopez NC, Valck C, Ramirez G, Rodriguez M, Ribeiro C, Orellana J, Maldonado I, Albini A, Anacona D, Lemus D, Aguilar L, Schwaeble W, Ferreira A (2010) Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin. PLoS Negl Trop Dis 4:e730CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    McLaughlin PJ, Cain JD, Titunick MB, Sassani JW, Zagon IS (2017) Topical naltrexone is a safe and effective alternative to standard treatment of diabetic wounds. Adv Wound Care 6:279–288CrossRefGoogle Scholar
  35. 35.
    Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M (1999) Calreticulin: one protein, one gene, many functions. Biochem J 344:281–292CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Nanney LB, Woodrell CD, Greives MR, Cardwell NL, Pollins AC, Bancroft TA, Chesser A, Michalak M, Rahman M, Siebert JW, Gold LI (2008) Calreticulin enhances porcine wound repair by diverse biological effects. Am J Pathol 173:610–630CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Okwueze MI, Cardwell NL, Pollins AC, Nanney LB (2007) Modulation of porcine wound repair with a transfected ErbB3 gene and relevant EGF-like ligands. J Invest Dermatol 127:1030–1041CrossRefPubMedGoogle Scholar
  38. 38.
    Park SA, Raghunathan VK, Shah NM, Teixeira L, Motta MJ, Covert J, Dubielzig R, Schurr M, Isseroff RR, Abbott NL, McAnulty J, Murphy CJ (2014) PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds. PLoS One 9:e104447CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Persson U, Willis M, Odegaard K, Apelqvist J (2002) The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data. Value Health 3(Suppl 1):39–46Google Scholar
  40. 40.
    Pike SE, Yao L, Setsuda J, Jones KD, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Atreya CD, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G (1999) Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 94:2461–2468PubMedGoogle Scholar
  41. 41.
    Piperigkou Z, Gotte M, Theocharis AD, Karamanos NK (2017) Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing. Adv Drug Deliv Rev. PubMedCrossRefGoogle Scholar
  42. 42.
    Rajkumar VS, Shiwen X, Bostrom M, Leoni P, Muddle J, Ivarsson M, Gerdin B, Denton CP, Bou-Gharios G, Black CM, Abraham DJ (2006) Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 169:2254–2265CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Rämet M, Lanot R, Zachary D, Manfruelli P (2002) JNK signaling pathway is required for efficient wound healing in drosophila. ‎Dev Biol 241:145–156PubMedGoogle Scholar
  44. 44.
    Ramirez G, Valck C, Molina MC, Ribeiro CH, Lopez N, Sanchez G, Ferreira VP, Billetta R, Aguilar L, Maldonado I, Cattan P, Schwaeble W, Ferreira A (2011) Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity. Immunobiology 216:265–273CrossRefPubMedGoogle Scholar
  45. 45.
    Shaw TJ, Martin P (2009) Wound repair at a glance. ‎J Cell Sci 122:3209–3213CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Sim RB, Moestrup SK, Stuart GR, Lynch NJ, Lu J, Schwaeble WJ, Malhotra R (1998) Interaction of C1q and the collectins with the potential receptors calreticulin (cClqR/collectin receptor) and megalin. Immunobiology 199:208–224CrossRefPubMedGoogle Scholar
  47. 47.
    Stojadinovic O, Brem H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M (2005) Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol 167:59–69CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778–784CrossRefPubMedGoogle Scholar
  49. 49.
    Valck C, Ramirez G, Lopez N, Ribeiro CH, Maldonado I, Sanchez G, Ferreira VP, Schwaeble W, Ferreira A (2010) Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin. Mol Immunol 47:1516–1521CrossRefPubMedGoogle Scholar
  50. 50.
    Zhang Y, Liu L, Jin L, Yi X, Dang E, Yang Y, Li C, Gao T (2014) Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes. J Invest Dermatol 134:183–191CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical Science, Faculty of Veterinary and Animal ScienceUniversity of ChileSantiagoChile
  2. 2.Department of Preventive Medicine, Faculty of Veterinary and Animal ScienceUniversity of ChileSantiagoChile
  3. 3.Department of Morphological Sciences, Faculty of ScienceUniversidad San SebastianSantiagoChile
  4. 4.Institute of Biomedical Sciences, Faculty of MedicineUniversity of ChileSantiagoChile

Personalised recommendations